Hebron Hospital General, Barcelona, Spain, 3Univeristy of Toronto, Toronto, ON, Canada, 4Auckland
City Hospital, Auckland, New Zealand, 5Gilead Sciences,
Foster City, CA, USA, 6Hopital Beaujon, Clichy, France. ****@****
Regression of fibrosis is an important clinical outcome for patients with CHB who achieve long term viral suppression with nucleos(t)ide therapy. It has been previously reported that up to 5 years of TDF therapy results in a regression of cirrhosis in 74% of patients.